Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (511-520 of 869) with videos related to

Pageof 87
Sort By:
Blood|September 13, 2003
Identification of genes modulated in multiple myeloma using genetically identical twin samplesNikhil C Munshi, Teru Hideshima, Daniel Carrasco, et al.
Blood|July 1, 2006
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implicationsMasood A Shammas, Paola Neri, Hemanta Koley, et al.
Cancer Research|June 11, 2009
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myelomaJing Zhang, Martin Sattler, Giovanni Tonon, et al.
British Journal of Haematology|December 18, 2012
Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational studyRachel Rosovsky, Fangxin Hong, Deanna Tocco, et al.
Cancer Management and Research|September 8, 2012
Lenalidomide for the treatment of relapsed and refractory multiple myelomaNiels Wcj van de Donk, Güllü Görgün, Richard Wj Groen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Prognostic significance of copy-number alterations in multiple myelomaHervé Avet-Loiseau, Cheng Li, Florence Magrangeas, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Molecular sequelae of proteasome inhibition in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2012
Lenalidomide enhances anti-myeloma cellular immunityKatarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, et al.
Bone|January 22, 2013
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myelomaSamantha Pozzi, Mariateresa Fulciniti, Hua Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapyChirayu G Patel, Andrew J Yee, Tyler A Scullen, et al.
Pageof 87

Showing results (511-520 of 869) with videos related to

Sort By:
Pageof 87
Blood|September 13, 2003
Identification of genes modulated in multiple myeloma using genetically identical twin samplesNikhil C Munshi, Teru Hideshima, Daniel Carrasco, et al.
Blood|July 1, 2006
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implicationsMasood A Shammas, Paola Neri, Hemanta Koley, et al.
Cancer Research|June 11, 2009
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myelomaJing Zhang, Martin Sattler, Giovanni Tonon, et al.
British Journal of Haematology|December 18, 2012
Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational studyRachel Rosovsky, Fangxin Hong, Deanna Tocco, et al.
Cancer Management and Research|September 8, 2012
Lenalidomide for the treatment of relapsed and refractory multiple myelomaNiels Wcj van de Donk, Güllü Görgün, Richard Wj Groen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Prognostic significance of copy-number alterations in multiple myelomaHervé Avet-Loiseau, Cheng Li, Florence Magrangeas, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Molecular sequelae of proteasome inhibition in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2012
Lenalidomide enhances anti-myeloma cellular immunityKatarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, et al.
Bone|January 22, 2013
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myelomaSamantha Pozzi, Mariateresa Fulciniti, Hua Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapyChirayu G Patel, Andrew J Yee, Tyler A Scullen, et al.
Pageof 87